Surgical oncology: Cancer risk reduction in BRCA mutation carriers

被引：5
|
作者：
Kirk R.
机构：
来源：
Nature Reviews Clinical Oncology | 2010年 / 7卷 / 11期
关键词：
D O I：
10.1038/nrclinonc.2010.157
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：609 / 609
相关论文
共 50 条
  • [21] Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be done
    Nahshon, Chen
    Segev, Yakir
    Schmidt, Meirav
    Lavie, Ofer
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (02) : 260 - 266
  • [22] ENDOMETRIAL CANCER RISK IN BRCA MUTATION CARRIERS: A PROSPECTIVE DATABASE STUDY
    Crosbie, E.
    Ryan, N.
    Wallace, A.
    Lalloo, F.
    Woodward, E.
    Clayton, R.
    Edmondson, R.
    Evans, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1203 - 1203
  • [23] Skin cancer risk in BRCA1/2 mutation carriers
    Navsaria, L.
    Haas, A.
    Corredor, J.
    Arun, B.
    Giordano, S.
    Nead, K.
    Wehner, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (09) : B12 - B12
  • [24] Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers
    Vicus, Danielle
    Rosen, Barry
    Lubinski, Jan
    Domchek, Susan
    Kauff, Noah D.
    Lynch, Henry T.
    Isaacs, Claudine
    Tung, Nadine
    Sun, Ping
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (01) : 135 - 137
  • [25] Skin cancer risk in BRCA1/2 mutation carriers
    Gumaste, P. V.
    Penn, L. A.
    Cymerman, R. M.
    Kirchhoff, T.
    Polsky, D.
    McLellan, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (06) : 1498 - 1506
  • [26] Cancer risk associated with exogenous hormone use in BRCA mutation carriers
    Kotsopoulos, J.
    CANCER RESEARCH, 2024, 84 (09)
  • [27] ENDOMETRIAL CANCER RISK IN BRCA MUTATION CARRIERS: A PROSPECTIVE DATABASE STUDY
    Crosbie, E.
    Ryan, N.
    Wallace, A.
    Lalloo, F.
    Woodward, E.
    Clayton, R.
    Edmondson, R.
    Evans, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 458 - 458
  • [28] Oophorectomy reduces risk of ovarian cancer in BRCA mutation carriers by 80%
    Nature Clinical Practice Oncology, 2006, 3 (10): : 526 - 527
  • [29] Defining cancer risks for BRCA germline mutation carriers:: implications for surgical prophylaxis
    Karlan, BY
    GYNECOLOGIC ONCOLOGY, 2004, 92 (02) : 519 - 520
  • [30] Breast & ovarian cancer risk in BRCA mutation carriers: Implications for prevention
    Catane, R
    Halle, D
    Kaufman, B
    Eisenberg, S
    Isaacson, R
    Chemy, N
    Lahad, A
    Hornreich, G
    Beller, U
    LevyLahad, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 37 - 37
12345